1. Home
  2. IDYA vs FIZZ Comparison

IDYA vs FIZZ Comparison

Compare IDYA & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$33.40

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

FIZZ

National Beverage Corp.

HOLD

Current Price

$33.33

Market Cap

3.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
FIZZ
Founded
2015
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.1B
IPO Year
2019
1991

Fundamental Metrics

Financial Performance
Metric
IDYA
FIZZ
Price
$33.40
$33.33
Analyst Decision
Strong Buy
Strong Sell
Analyst Count
14
1
Target Price
$49.42
$35.00
AVG Volume (30 Days)
926.1K
445.3K
Earning Date
11-04-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.50
EPS
N/A
1.99
Revenue
$214,834,000.00
$1,199,525,000.00
Revenue This Year
$2,434.86
$2.80
Revenue Next Year
N/A
$2.19
P/E Ratio
N/A
$17.01
Revenue Growth
5377.66
0.96
52 Week Low
$13.45
$32.21
52 Week High
$37.08
$47.89

Technical Indicators

Market Signals
Indicator
IDYA
FIZZ
Relative Strength Index (RSI) 49.65 43.46
Support Level $33.12 $32.32
Resistance Level $37.08 $35.91
Average True Range (ATR) 1.47 1.04
MACD -0.36 0.01
Stochastic Oscillator 5.30 25.38

Price Performance

Historical Comparison
IDYA
FIZZ

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

Share on Social Networks: